Canaccord Genuity Downgrades UiPath to Hold, Raises Price Target to $17
Benzinga Newsdesk 2 months ago
NewsDowngradesAnalyst RatingsPrice Target
Canaccord Genuity analyst Kingsley Crane downgrades UiPath (NYSE:PATH) from Buy to Hold and raises the price target from $15 to $17.
Canaccord Genuity analyst Kingsley Crane downgrades UiPath (NYSE:PATH) from Buy to Hold and raises the price target from $15 to $17.